Objective: To investigate the clinical value and feasibility of ultrasound and contrast-enhanced ultrasound in adrenal tumor patients. METHODS: A total of 60 patients with adrenal tumor diagnosed from May 2016 to December 2017 were selected. All patients were finally diagnosed by pathological histological examination. Before operation, all patients underwent ultrasound and contrast-enhanced ultrasound examination. The results of contrast-enhanced ultrasonography and contrast-enhanced ultrasonography were compared with the results of surgical pathology. The diagnostic value and feasibility of ultrasound and contrast-enhanced ultrasound in early adrenal tumors were analyzed. Results: 60 cases of adrenal tumors were diagnosed by pathological examination. 53 cases were treated by surgery and 7 cases were confirmed by ultrasound-guided biopsy. Among the tumors, the top three were cortical adenoma, pheochromocytoma, and myeloid lipoma, which accounted for 53.33%, 13.33%, and 10.00%, respectively; adrenal tumor patients completed ultrasound and contrast-enhanced ultrasound imaging. Finally, 53 cases were diagnosed with tumor ultrasound; 58 cases were diagnosed with combined ultrasound and contrast-enhanced ultrasound; the sensitivity and specificity of tumor ultrasound in adrenal tumors were higher than those of single tumor and ultrasound contrast (P<0.05). The diameters of the adenomas diagnosed by conventional ultrasonography were 9-37 mm, averaged 23.14±4.61 mm, and the internal appearance was homogeneous and fine-spot echoes. The borders were smooth and neat, and the capsule was complete; 7 pheochromocytoma diameters. (40-71) mm, average (56.74±4.51) mm, homogeneous hypoecho inside, clear echo at the boundary; diameter of myeloid lipoma in 31 cases (31-55) mm, average (38.42±4.62) mm , Circular homogenous echoes, regular rules, clear boundaries. In the ultrasound contrast agent examination, the contrast agent enters the lesion site, the boundary of the tumor is clearer, and the adenoma, pheochromocytoma, and myeloid lipoma are filled with the contrast agent faster, and the peak intensity is lower than the surrounding liver parenchyma or is equivalent to the liver parenchyma. . The adenoma patients were evenly enhanced around the contrast agent, and there was scattered intra-contrast agent; the myeloid lipomas were not evenly enhanced by contrast-enhanced ultrasound, and the center was high and the peripheral echo was low. Conclusion: Tumor ultrasound can improve the clinical diagnosis rate in adrenal tumors, and contrast-enhanced ultrasound can show the perfusion of adrenal tumors, which can be used as a supplement to tumor ultrasound. Tumor ultrasound and contrast-enhanced ultrasound can realize the diagnosis and identification of adrenal tumors, which is worthy of promotion. application.